Semglee and lantus the same?

Short answer: not identical, but Semglee is a biosimilar of Lantus.

- What they are:
- Lantus = brand-name insulin glargine (long-acting insulin).
- Semglee = a biosimilar insulin glargine (made to be highly similar to Lantus).

- Are they the same?
- They contain the same active ingredient and are used the same way, but they are produced by different manufacturers. Biosimilars are not considered exact copies like generics, but they are designed to be clinically very similar in safety and effectiveness.

- Interchangeability (US):
- Semglee has been designated interchangeable with Lantus in the US, meaning many pharmacies can substitute it for Lantus at the counter if allowed by state law. Dosing is intended to be 1:1 (no dose change expected), but substitution and any switch should be supervised by your clinician.

- Differences you might notice:
- Device/packaging (different pens or vials).
- Inactive ingredients and supply details can differ slightly.
- Availability and insurance coverage can vary.

- What to do if you’re considering switching:
- Talk with your healthcare provider and pharmacist.
- If you switch, monitor your blood sugar closely for a couple of days after the change.
- Don’t switch insulin products without medical advice.

If you tell me your country or what you’re trying to figure out (cost, coverage, how to switch, etc.), I can tailor the details.